| 000 | 01759 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516120327.0 | ||
| 264 | 0 | _c20130404 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a2210-7762 | ||
| 024 | 7 |
_a10.1016/j.cancergen.2012.09.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Sung-Eun | |
| 245 | 0 | 0 |
_aThe long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate. _h[electronic resource] |
| 260 |
_bCancer genetics _cNov 2012 |
||
| 300 |
_a563-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Chronic-Phase _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChoi, Soo Young | |
| 700 | 1 | _aBang, Ju-Hee | |
| 700 | 1 | _aKim, Soo-Hyun | |
| 700 | 1 | _aJang, Eun-Jung | |
| 700 | 1 | _aByeun, Ji-Young | |
| 700 | 1 | _aPark, Jin Eok | |
| 700 | 1 | _aJeon, Hye-Rim | |
| 700 | 1 | _aOh, Yun Jeong | |
| 700 | 1 | _aKim, Myungshin | |
| 700 | 1 | _aKim, Dong-Wook | |
| 773 | 0 |
_tCancer genetics _gvol. 205 _gno. 11 _gp. 563-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cancergen.2012.09.003 _zAvailable from publisher's website |
| 999 |
_c22224949 _d22224949 |
||